It is time to stop decades of failure . We have a lot to do to EndTB by 2030, said Professor (Dr) Guy Marks, President of the ...

T2 Biosystems, Inc., a Delaware-based company specializing in innovative diagnostics, recently reported its financial and operational updates for the quarter ending September 30, 2024. The company ...

Artificial intelligence-powered rare disease diagnostics firm 3billion Inc. debuted on the tech-heavy Kosdaq board of the Korea Exchange Nov. 14 with its IPO raising about ₩14.4 billion (US$10.25 ...

The manuscript was released online ahead of publication in The Journal of Molecular Diagnostics. AMP convened a SARS-CoV-2 Whole Genome Sequencing Working ... Through the efforts of its board of ...

A sharp improvement in math proficiency by Buffalo Public Schools' economically disadvantaged third graders last year ...